• 1. Synthesis and characterization of the physicochemical and magnetic properties for perfluoroalkyl ester and Fe(iii) carboxylate-based hydrophobic magnetic ionic liquids
  Omprakash Nacham,Kevin D. Clark,Jared L. Anderson RSC Adv. 2016 6 11109
• 2. The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl)triphenylphosphonium bromide (AP39)
  Sophie Le Trionnaire,Alexis Perry,Bartosz Szczesny,Csaba Szabo,Paul G. Winyard,Jacqueline L. Whatmore,Mark E. Wood,Matthew Whiteman Med. Chem. Commun. 2014 5 728
• 3. Cyclo-depolymerisation of polyundecanoate and related polyesters: characterisation of cyclic oligoundecanoates and related cyclic oligoesters
  Clare L. Ruddick,Philip Hodge,Yang Zhuo,Roy L. Beddoes,Madeleine Helliwell J. Mater. Chem. 1999 9 2399
• 4. MC-1. A “designer” surfactant engineered for peptide synthesis in water at room temperature
  Margery Cortes-Clerget,Summer E. Spink,Gregory P. Gallagher,Laurent Chaisemartin,Edith Filaire,Jean-Yves Berthon,Bruce H. Lipshutz Green Chem. 2019 21 2610
• 5. The synthesis of the very long chain polyunsaturated fatty acid (VLC-PUFA) 32:6 n-3
  Alexander Wade,Rameshu Rallabandi,Steven Lucas,Catrina Oberg,Aruna Gorusupudi,Paul S. Bernstein,Jon D. Rainier Org. Biomol. Chem. 2021 19 5563

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

10-Bromodecanoic acid (CAS No. 50530-12-6): Applications and Recent Research Developments

10-Bromodecanoic acid, with the chemical formula C₁₀H₁₉BrO₂, is a significant compound in the field of organic synthesis and pharmaceutical research. Its molecular structure features a decanoic acid backbone substituted with a bromine atom at the terminal carbon, making it a versatile intermediate for various chemical transformations. This compound has garnered considerable attention due to its utility in synthesizing complex molecules, particularly in the development of novel therapeutic agents.

The CAS No. 50530-12-6 designation uniquely identifies this substance, ensuring consistency and accuracy in its documentation and use across different scientific disciplines. The presence of the bromine atom in 10-Bromodecanoic acid enhances its reactivity, enabling it to participate in various coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing biaryl and heteroaryl structures, respectively.

In recent years, the pharmaceutical industry has seen a surge in the demand for small-molecule inhibitors targeting specific biological pathways. 10-Bromodecanoic acid has emerged as a valuable building block in this context. Its ability to undergo selective functionalization allows chemists to design molecules with tailored properties for drug discovery. For instance, researchers have utilized this compound to synthesize derivatives that exhibit inhibitory activity against enzymes involved in cancer metabolism.

One of the most compelling applications of 10-Bromodecanoic acid is in the field of medicinal chemistry. The bromine substituent facilitates palladium-catalyzed cross-coupling reactions, which are essential for constructing complex drug scaffolds. A notable example is its use in generating novel kinase inhibitors, which have shown promise in preclinical studies for their ability to modulate signaling pathways implicated in chronic diseases.

The versatility of 10-Bromodecanoic acid extends beyond pharmaceuticals into materials science. Researchers have explored its use in polymer chemistry, where it serves as a monomer or cross-linking agent to develop advanced materials with specific mechanical and thermal properties. These materials find applications in coatings, adhesives, and even biodegradable polymers.

The synthesis of 10-Bromodecanoic acid typically involves the bromination of decanoic acid or related derivatives using brominating agents such as N-bromosuccinimide (NBS). This reaction is often conducted under controlled conditions to ensure high yield and purity. The resulting product can then be further modified through various chemical transformations to achieve the desired molecular architecture.

In academic research, 10-Bromodecanoic acid has been employed to study reaction mechanisms and develop new synthetic methodologies. Its role as a substrate in organic transformations has provided insights into catalytic processes and reaction pathways, contributing to the broader understanding of organic chemistry principles.

The impact of 10-Bromodecanoic acid on drug discovery is further highlighted by its incorporation into libraries of compounds screened for biological activity. High-throughput screening (HTS) campaigns often utilize such libraries to identify lead compounds with potential therapeutic value. The structural features provided by CAS No. 50530-12-6-marked compounds are instrumental in this process, enabling the rapid identification of molecules with desirable pharmacological properties.

The future prospects of 10-Bromodecanoic acid are promising, with ongoing research exploring its role in developing next-generation therapeutics. Innovations in synthetic chemistry continue to unlock new possibilities for this compound, suggesting that its importance will only grow as our understanding of biological systems expands.

• 2067-33-6(5-Bromovaleric acid)
• 73367-80-3(12-Bromododecanoic acid)
• 4224-70-8(6-Bromohexanoic acid)
• 17696-11-6(8-Bromooctanoic acid)
• 2536-35-8(16-Bromohexadecanoic acid)
• 30515-28-7(7-Bromoheptanoic acid)
• 41059-02-3(9-Bromononanoic acid)
• 42932-62-7(5-Bromopentanoic-3,3,4,4-d4 Acid)
• 2834-05-1(11-Bromoundecanoic acid)
• 13099-35-9(16-Bromoheptadecanoic acid)